Picture of Edwards Lifesciences logo

EW Edwards Lifesciences Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m+5.2%
3m+12.83%
6m+11.57%
1yr-10.55%
Volume Change (%)
10d/3m-8.94%
Price vs... (%)
52w High-1.55%
50d MA+11.02%
200d MA+19.38%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)33.13
PEG Ratio (f)5.15
EPS Growth (f)6.87%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value8.48
Price to Tang. Book11.35
Price to Free Cashflow89.59
Price to Sales9.39
EV to EBITDA33

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital18.78%
Return on Equity22.52%
Operating Margin25.55%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue$m4,3484,386.35,232.55,382.46,004.86,519.417,161.0210.03%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+9.14+4.98+28.25+5.32+3.15+5.18+12.35n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Edwards Lifesciences EPS forecast chart

Profile Summary

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It also develops hemodynamic and noninvasive brain and tissue oxygenation monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating severe symptomatic aortic stenosis. It conducts operations worldwide and is managed in various geographical regions, including the United States, Europe, Japan, and Rest of World. It sells products that are used to treat advanced cardiovascular disease in all regions.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
September 10th, 1999
Public Since
March 27th, 2000
No. of Shareholders
7,599
No. of Employees
19,800
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNew York Stock Exchange
Shares in Issue
601,300,000
Blurred out image of a map
Address
One Edwards Way, IRVINE, 92614
Web
https://www.edwards.com
Phone
+1 9492502500
Auditors
PricewaterhouseCoopers LLP

EW Share Price Performance

Upcoming Events for EW

Q1 2024 Edwards Lifesciences Corp Earnings Release

Edwards Lifesciences Corp Annual Shareholders Meeting

Q2 2024 Edwards Lifesciences Corp Earnings Release

Similar to EW

Picture of Abbott Laboratories logo

Abbott Laboratories

us flag iconNew York Stock Exchange

Picture of Agilent Technologies logo

Agilent Technologies

us flag iconNew York Stock Exchange

Picture of Agiliti logo

Agiliti

us flag iconNew York Stock Exchange

Picture of Alcon AG logo

Alcon AG

us flag iconNew York Stock Exchange

Picture of Artivion logo

Artivion

us flag iconNew York Stock Exchange

FAQ